Resistant E.coli, S. aureus Community Unit Emergency (R.E.S.C.U.E.)
R.E.S.C.U.E. utilizes data and analytics, surveys, Kirby-Bauer disk diffusion susceptibility testing (i.e., standard methods used), AI-machine learning algorithms, AMR distribution to identify gaps, digitize data, regulatory compliance, enhance security of data, improve healthcare access, and create a bacterial AMR virtual library for further analysis and research development.
Rozan Attilli, (PhD): expert in microbiology & clinical chemistry, conducting research at Laval University & Hannover Medical School. Member of PMTA, RNA society, Organization of women in developing countries (OWSD)
- Innovation
- Integration
AMR is acknowledged as the biggest obstacle facing humanity in the fight against infectious illnesses. deKraker et al state in the absence of immediate action, the annual death toll from antibiotic-resistant bacteria by 2050 is expected to surpass 10 million (13).
With a population of at least 5 million, in Palestine, AMR deaths are significantly higher than other non-communicable diseases, respiratory infections, tuberculosis, digestive diseases, self-harm and interpersonal violence (12). Low & middle income countries (LMIC) face higher burden for AMR than other nations (14, 15).
In Palestine, there are an estimated 735 private medical & governmental labs, still lacking reliable AMR data acquisition, processing, storage and dissemination, impacted by lack of knowledge, skills of medical technologists specifically and health professionals as a whole. Insufficient training, monitoring led to inadequate AMR control.
Poor reporting compounded by unavailability of applications to support laboratory technologists.
Mapping: lack of available data on multi-sectoral facilities providing testing while mapping ‘problem areas’ , i.e. high rates of AMR infections.
Swabbing: AMR barcoded swabs & data are missing.
Library establishment: absence of a library for AMR genes, that helps in research and development
AMR disease impacts all aspects of life, especially of the marginalized and underserved.

The solution serves the Palestinian population; to address their needs of improved antibiotics effectiveness by improving detection, reporting and management of patients. To eventually be implemented for other AMR bacteria in Palestine.
The primary beneficiaries are health professionals, medical technicians, to address their needs for faster, more accurate reporting of AMR by empowering them with training and a digital mobile application and support from the research team.
Raise awareness among those physicians, lab technicians, and public about AMR through identifying the gaps in knowledge and practice
Mapping the facilities in the Palestinian cities, to assist health care professionals, researchers, and academics in their need to identify centers affected by AMR, monitor resistance, and serve the population.
Establish a system and promote the usage of barcoded swabs and establish a bacterial AMR virtual library to improve AMR bacterial identification and monitoring.
- Pilot: A project, initiative, venture, or organisation deploying its research, product, service, or business/policy model in at least one context or community
